![]() The American Society of Clinical Oncology (ASCO) meeting last week was a bit of a snoozer. As usually, lots of deal making and networking. What differentiated this year’s ASCO was the lack of major drug announcements. ASCO is normally one of the highlights of my year, but this year proved to be a disappointment. |
Write a comment:
|